Announcements Trials
Browse Landscape

Phase

Phase NA 5Phase EARLY_PHASE1 1

Status

Recruiting 2Terminated 1Not yet recruiting 1Completed 1

Sponsor Class

OTHER 5

Study Type

Interventional 5

Sponsor

Cancer Type

Gastrointestinal 5Gynecologic 3Breast 3

Conditions

Breast Neoplasms 10Colorectal Neoplasms 5Ovarian Neoplasms 4Endometrial Neoplasms 4Colorectal Neoplasms, Hereditary Nonpolyposis 4Prostatic Neoplasms 3Rectal Neoplasms 2Hereditary Breast and Ovarian Cancer Syndrome 2Colonic Neoplasms 2Carcinoma, Intraductal, Noninfiltrating 2Women Age 35+ Qualifies if >15% Lifetime Risk of Breast Cancer as Defined by IBIS Version 8 1Wilms Tumor 1Pyloric Stenosis, Hypertrophic 1Primary Ovarian Insufficiency 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Polycystic Ovary Syndrome 1Pancreatic Neoplasms 1Pancreatic Ductal Adenocarcinoma 1Neurofibromatosis 1 1Neoplastic Syndromes, Hereditary 1Neoplasms, Unknown Primary 1Neoplasm Metastasis 1Multiple Myeloma 1Lymphoproliferative Disorders 1Lipodystrophy, Familial Partial 1Leukemia, Myeloid, Acute 1Histiocytosis, Non-Langerhans-Cell 1Histiocytosis, Langerhans-Cell 1Hepatic Veno-Occlusive Disease 1Hematopoietic and Lymphatic System Neoplasm 1

Interventions

Colonoscopy 44Standard of Care 28Early Intervention, Educational 23Methods 22Blood Specimen Collection 21Exercise 20Educational Status 19Interviews as Topic 13Surveys and Questionnaires 12Patient Navigation 12Counseling 12Practice Guidelines as Topic 11Endoscopic Mucosal Resection 10Drug Therapy 10Oxaliplatin 9Irinotecan 8Fluorouracil 8Surgical Procedures, Operative 7Preoperative Exercise 7Lidocaine 7Bevacizumab 7Therapeutics 6Resistance Training 6Occult Blood 6Narrow Band Imaging 6Mass Screening 6Leucovorin 6Diet 6Decision Support Techniques 6Control Groups 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase NA × Colorectal Neoplasms × Genetic Testing × Clear all
NCT05649072 2026-05-22

Identifying Underserved Individuals inTexas With Hereditary Cancer Risk Using Mobile Mammography Units and Telegenetics.

M.D. Anderson Cancer Center

Phase NA Recruiting
1,000 enrolled
BreastGastrointestinalGynecologic

Breast Neoplasms, Ovarian Neoplasms, Colorectal Neoplasms

NCT02664389 2026-05-06

PANEL

University Hospital, Rouen

Phase NA Terminated
289 enrolled
BreastGastrointestinalGynecologic

Breast Neoplasms, Ovarian Neoplasms, Colorectal Neoplasms

NCT05694559 2026-02-19

Connecting Black Families in Houston, Texas to Hereditary Cancer Genetic Counseling, Genetic Testing, and Cascade Testing by Using a Simple Genetic Risk Screening Tool and Telegenetics

M.D. Anderson Cancer Center

Phase NA Recruiting
1,000 enrolled
BreastGastrointestinal

Breast Neoplasms, Colorectal Neoplasms

NCT07143487 2025-09-16

Family Communications After Genetic Testing

Alliance for Clinical Trials in Oncology

Phase NA Not yet recruiting
4,186 enrolled
Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT01850654 2018-06-28

OCCPI

Ohio State University Comprehensive Cancer Center

Phase NA Completed
3,470 enrolled
GastrointestinalGynecologic

Colonic Neoplasms, Colorectal Neoplasms, Hereditary Nonpolyposis, Rectal Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡